IL1RL1
Interleukin-1 receptor-like 1
Also known as: DER4, FIT-1, IL33R, ILRL1_HUMAN, ST2, ST2L, ST2V, T1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01638
- Gene
- IL1RL1
- Ensembl
- ENSG00000115602
- Chromosome
- 2
- Canonical length
- 556 aa
- Protein class
- Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane,Focal adhesion sites,Cytosol
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a member of the interleukin 1 receptor family. Studies of the similar gene in mouse suggested that this receptor can be induced by proinflammatory stimuli, and may be involved in the function of helper T cells. This gene, interleukin 1 receptor, type I (IL1R1), interleukin 1 receptor, type II (IL1R2) and interleukin 1 receptor-like 2 (IL1RL2) form a cytokine receptor gene cluster in a region mapped to chromosome 2q12. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
556 residues, UniProt reviewed canonical sequence.
>Q01638|IL1RL1
1 MGFWILAILT ILMYSTAAKF SKQSWGLENE ALIVRCPRQG KPSYTVDWYY SQTNKSIPTQ
61 ERNRVFASGQ LLKFLPAAVA DSGIYTCIVR SPTFNRTGYA NVTIYKKQSD CNVPDYLMYS
121 TVSGSEKNSK IYCPTIDLYN WTAPLEWFKN CQALQGSRYR AHKSFLVIDN VMTEDAGDYT
181 CKFIHNENGA NYSVTATRSF TVKDEQGFSL FPVIGAPAQN EIKEVEIGKN ANLTCSACFG
241 KGTQFLAAVL WQLNGTKITD FGEPRIQQEE GQNQSFSNGL ACLDMVLRIA DVKEEDLLLQ
301 YDCLALNLHG LRRHTVRLSR KNPIDHHSIY CIIAVCSVFL MLINVLVIIL KMFWIEATLL
361 WRDIAKPYKT RNDGKLYDAY VVYPRNYKSS TDGASRVEHF VHQILPDVLE NKCGYTLCIY
421 GRDMLPGEDV VTAVETNIRK SRRHIFILTP QITHNKEFAY EQEVALHCAL IQNDAKVILI
481 EMEALSELDM LQAEALQDSL QHLMKVQGTI KWREDHIANK RSLNSKFWKH VRYQMPVPSK
541 IPRKASSLTP LAAQKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL1RL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 188 nTPM
Expression across tissuesHPA
Tissue
- placenta: 188 nTPM
- lung: 159 nTPM
- kidney: 117 nTPM
- choroid plexus: 58 nTPM
- adrenal gland: 32 nTPM
- stomach: 24 nTPM
Single-cell type
- mast cells: 329 nCPM
- epididymal basal cells: 120 nCPM
- pericytes: 38 nCPM
- hepatic stellate cells: 26 nCPM
- neutrophils: 20 nCPM
- vascular endothelial cells: 17 nCPM
Immune cell
- basophil: 38 nTPM
- eosinophil: 29 nTPM
- NK-cell: 0.5 nTPM
- MAIT T-cell: 0.4 nTPM
- total PBMC: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- choroid plexus: 15 nTPM
- basal ganglia: 11 nTPM
- thalamus: 11 nTPM
- white matter: 8.8 nTPM
- cerebral cortex: 8.2 nTPM
- spinal cord: 7.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.19
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- immune response
- inflammatory response
- interleukin-33-mediated signaling pathway
- macrophage differentiation
- negative regulation of T-helper 1 type immune response
- negative regulation of type II interferon production
- positive regulation of chemokine production
- positive regulation of inflammatory response
- positive regulation of interleukin-5 production
- positive regulation of macrophage activation
- response to wounding
- signal transduction
Molecular functions
- cytokine receptor activity
- interleukin-1 receptor activity
- interleukin-33 receptor activity
- NAD+ nucleosidase activity, cyclic ADP-ribose generating
- interleukin-33 binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Toll/interleukin-1 receptor homology (TIR) domain
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Interleukin-1 receptor type I/II
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Interleukin-1 receptor family
- Toll/interleukin-1 receptor homology (TIR) domain superfamily
- Immunoglobulin-like domain superfamily
- TIR domain
- Immunoglobulin I-set domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL1RL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL1RL1 as an antibody target. Whether an autoantibody or antibody against IL1RL1 could matter depends on whether native IL1RL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL1RL1 is annotated at the cell surface, where native IL1RL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL1RL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...